(Q42650570)
Statements
1 reference
Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease (English)
1 reference
Patricia Limousin
1 reference
Thomas Foltynie
1 reference
Andrew Lees
1 reference
Atbin Djamshidian
1 reference
John Dickson
1 reference
Iciar Aviles-Olmos
1 reference
Zinovia Kefalopoulou
1 reference
Joshua Kahan
1 reference
Richard Wyse
1 reference
Peter Ell
1 reference
Peter Whitton
1 reference
Tom Isaacs
1 reference
1 January 2014
1 reference
1 reference
4
1 reference
3
1 reference
337-344
1 reference
Identifiers
1 reference
1 reference